Avenique Receives BSE Trading Approval for 500k Shares

Avenique Limited has received trading approval from BSE Limited for 500,000 equity shares of face value ₹2 each. The approval was granted via BSE notice number 20261028-28 dated October 28, 2026.

The shares were allocated through two mechanisms as part of an NCLT-approved resolution plan:

• 5,00,000 shares allotted to Successful Resolution Applicants (SRA) and its group of promoters on preferential basis
• Shares allotted to Existing Public Shareholders by way of Reduction of Share Capital on Proportionate basis

The resolution plan was approved by the Hon'ble NCLT, Mumbai Bench vide Order dated March 4, 2025.

Trading Commencement

The approved shares will commence trading on BSE starting Thursday, November 5, 2026.

Impact Assessment

According to the Annexure-A disclosure:

• The trading approval enables admission of 5,00,000 equity shares for trading on BSE
• No withdrawal, cancellation, or suspension of the license/approval has occurred
• The validity period of the approval is noted as "Not Applicable"
• No monetary impact or corrective actions are required as this is an approval grant